Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
they never finish the series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in the unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose of Shingrix on unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: they never finish the series). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 26-FEB-2025 The reporter reported on 26-Feb-2025 if a patient had not finish the series and they did not had it in the last 3 to 5 years, could we restart the series or just get one more dose. The reporter mentioned that this situation was related to 4 to 5 patients, but they did not had any patients Personal Information. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.